To join a sickle cell disease clinical trial in United States, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United States directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.

What phases are sickle cell disease trials in United States?

Active sickle cell disease trials in United States span Phase 1, Phase 1, Phase 2, Phase 2, Phase 3, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.

Browse More

All United States Trials → Global sickle cell disease Trials → All Countries → All Trials →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology

Active Trials in United States (20)

Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait

Functional Ovarian Reserve in Sickle Cell Disease

Virtual Reality for SCD VOC

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

Early Life Exposures Among Children With Sickle Cell Disease

Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Cannabidiol in Sickle Cell Disease

Gene Editing For Sickle Cell Disease

Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease

Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Frequently Asked Questions